Pregabalin Accord

Country: Kesatuan Eropah

Bahasa: Inggeris

Sumber: EMA (European Medicines Agency)

Beli sekarang

Risalah maklumat Risalah maklumat (PIL)
09-01-2023
Ciri produk Ciri produk (SPC)
09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
06-07-2017

Bahan aktif:

pregabalin

Boleh didapati daripada:

Accord Healthcare S.L.U.

Kod ATC:

N03AX16

INN (Nama Antarabangsa):

pregabalin

Kumpulan terapeutik:

Antiepileptics,

Kawasan terapeutik:

Anxiety Disorders; Epilepsy

Tanda-tanda terapeutik:

EpilepsyPregabalin Accord is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.Generalised Anxiety DisorderPregabalin Accord is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Ringkasan produk:

Revision: 15

Status kebenaran:

Authorised

Tarikh kebenaran:

2015-08-28

Risalah maklumat

                                78
B. PACKAGE LEAFLET
79
PACKAGE LEAFLET: INFORMATION FOR THE USER
PREGABALIN ACCORD 25 MG HARD CAPSULES,
PREGABALIN ACCORD 50 MG HARD CAPSULES,
PREGABALIN ACCORD 75 MG HARD CAPSULES,
PREGABALIN ACCORD 100 MG HARD CAPSULES,
PREGABALIN ACCORD 150 MG HARD CAPSULES,
PREGABALIN ACCORD 200 MG HARD CAPSULES,
PREGABALIN ACCORD 225 MG HARD CAPSULES,
PREGABALIN ACCORD 300 MG HARD CAPSULES
pregabalin
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU
.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects , talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Pregabalin Accord is and what it is used for
2.
What you need to know before you take Pregabalin Accord
3.
How to take Pregabalin Accord
4.
Possible side effects
5.
How to store Pregabalin Accord
6.
Contents of the pack and other information
1.
WHAT PREGABALIN ACCORD IS AND WHAT IT IS USED FOR
Pregabalin Accord belongs to a group of medicines used to treat
epilepsy, neuropathic pain and
Generalised Anxiety Disorder (GAD) in adults.
Peripheral and central neuropathic pain
This medicine is used to treat long lasting pain caused by damage to
the nerves. A variety of diseases
can cause peripheral neuropathic pain, such as diabetes or shingles.
Pain sensations may be described
as hot, burning, throbbing, shooting, stabbing, sharp, cramping,
aching, tingling, numbness, pins and
needles. Peripheral and central neuropathic pain may also be
associated with mood changes, sleep
disturbance, fatigue (tiredness), and can have an impact on physical
and social functioning and overall
quality of life.
Epilepsy
This medicine is used to treat a certain form of epilepsy (partial
                                
                                Baca dokumen lengkap
                                
                            

Ciri produk

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Pregabalin Accord 25 mg hard capsules
Pregabalin Accord 50 mg hard capsules
Pregabalin Accord 75 mg hard capsules
Pregabalin Accord 100 mg hard capsules
Pregabalin Accord 150 mg hard capsules
Pregabalin Accord 200 mg hard capsules
Pregabalin Accord 225 mg hard capsules
Pregabalin Accord 300 mg hard capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Pregabalin Accord 25 mg hard capsules
Each hard capsule contains 25 mg of pregabalin.
Pregabalin Accord 50 mg hard capsules
Each hard capsule contains50 mg of pregabalin.
Pregabalin Accord 75 mg hard capsules
Each hard capsule contains 75 mg of pregabalin.
Pregabalin Accord 100 mg hard capsules
Each hard capsule contains 100 mg of pregabalin.
Pregabalin Accord 150 mg hard capsules
Each hard capsule contains 150 mg of pregabalin.
Pregabalin Accord 200 mg hard capsules
Each hard capsule contains 200 mg of pregabalin.
Pregabalin Accord 225 mg hard capsules
Each hard capsule contains 225 mg of pregabalin.
Pregabalin Accord 300 mg hard capsules
Each hard capsule contains 300 mg of pregabalin
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Hard capsule
Pregabalin Accord 25 mg hard capsules
White opaque/ White opaque, size “4” hard gelatin capsules
imprinted with ‘‘PG’ on cap and ‘25’ on
body. Each capsule is approximately 14.4 mm in length.
Pregabalin Accord 50 mg hard capsules
White opaque/ White opaque, size “3” hard gelatin capsules
imprinted with ‘PG’ on cap and ‘50’ on
body. Each capsule is approximately 15.8 mm in length.
Pregabalin Accord 75 mg hard capsules
Red opaque/ White opaque, size “4” hard gelatin capsules imprinted
with ‘PG’ on cap and ‘75’ on
body. Each capsule is approximately 14.4 mm in length.
Pregabalin Accord 100 mg hard capsules
3
Red opaque/ Red opaque, size “3” hard gelatin capsules imprinted
with ‘PG’ on cap and ‘100’ on
body. Each capsule is approximately 15.8 mm in length.
Pregabalin Accord 15
                                
                                Baca dokumen lengkap
                                
                            

Dokumen dalam bahasa lain

Risalah maklumat Risalah maklumat Bulgaria 09-01-2023
Ciri produk Ciri produk Bulgaria 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Bulgaria 06-07-2017
Risalah maklumat Risalah maklumat Sepanyol 09-01-2023
Ciri produk Ciri produk Sepanyol 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Sepanyol 06-07-2017
Risalah maklumat Risalah maklumat Czech 09-01-2023
Ciri produk Ciri produk Czech 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Czech 06-07-2017
Risalah maklumat Risalah maklumat Denmark 09-01-2023
Ciri produk Ciri produk Denmark 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Denmark 06-07-2017
Risalah maklumat Risalah maklumat Jerman 09-01-2023
Ciri produk Ciri produk Jerman 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Jerman 06-07-2017
Risalah maklumat Risalah maklumat Estonia 09-01-2023
Ciri produk Ciri produk Estonia 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Estonia 06-07-2017
Risalah maklumat Risalah maklumat Greek 09-01-2023
Ciri produk Ciri produk Greek 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Greek 06-07-2017
Risalah maklumat Risalah maklumat Perancis 09-01-2023
Ciri produk Ciri produk Perancis 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Perancis 06-07-2017
Risalah maklumat Risalah maklumat Itali 09-01-2023
Ciri produk Ciri produk Itali 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Itali 06-07-2017
Risalah maklumat Risalah maklumat Latvia 09-01-2023
Ciri produk Ciri produk Latvia 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Latvia 06-07-2017
Risalah maklumat Risalah maklumat Lithuania 09-01-2023
Ciri produk Ciri produk Lithuania 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Lithuania 06-07-2017
Risalah maklumat Risalah maklumat Hungary 09-01-2023
Ciri produk Ciri produk Hungary 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Hungary 06-07-2017
Risalah maklumat Risalah maklumat Malta 09-01-2023
Ciri produk Ciri produk Malta 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Malta 06-07-2017
Risalah maklumat Risalah maklumat Belanda 09-01-2023
Ciri produk Ciri produk Belanda 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Belanda 06-07-2017
Risalah maklumat Risalah maklumat Poland 09-01-2023
Ciri produk Ciri produk Poland 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Poland 06-07-2017
Risalah maklumat Risalah maklumat Portugis 09-01-2023
Ciri produk Ciri produk Portugis 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Portugis 06-07-2017
Risalah maklumat Risalah maklumat Romania 09-01-2023
Ciri produk Ciri produk Romania 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Romania 06-07-2017
Risalah maklumat Risalah maklumat Slovak 09-01-2023
Ciri produk Ciri produk Slovak 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Slovak 06-07-2017
Risalah maklumat Risalah maklumat Slovenia 09-01-2023
Ciri produk Ciri produk Slovenia 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Slovenia 06-07-2017
Risalah maklumat Risalah maklumat Finland 09-01-2023
Ciri produk Ciri produk Finland 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Finland 06-07-2017
Risalah maklumat Risalah maklumat Sweden 09-01-2023
Ciri produk Ciri produk Sweden 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Sweden 06-07-2017
Risalah maklumat Risalah maklumat Norway 09-01-2023
Ciri produk Ciri produk Norway 09-01-2023
Risalah maklumat Risalah maklumat Iceland 09-01-2023
Ciri produk Ciri produk Iceland 09-01-2023
Risalah maklumat Risalah maklumat Croat 09-01-2023
Ciri produk Ciri produk Croat 09-01-2023
Laporan Penilaian Awam Laporan Penilaian Awam Croat 06-07-2017

Cari amaran yang berkaitan dengan produk ini